(19)
(11) EP 1 353 937 A2

(12)

(88) Date of publication A3:
06.03.2003

(43) Date of publication:
22.10.2003 Bulletin 2003/43

(21) Application number: 01994329.9

(22) Date of filing: 31.12.2001
(51) International Patent Classification (IPC)7: C07H 21/04, C07K 5/00, A61K 39/395, C12N 15/00, G01N 33/53
(86) International application number:
PCT/US0149/440
(87) International publication number:
WO 0205/9264 (01.08.2002 Gazette 2002/31)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 29.12.2000 US 751181

(71) Applicant: BIO-TECHNOLOGY GENERAL CORPORATION
Iselin, NJ 08830 (US)

(72) Inventors:
  • HAGAI, Yocheved
    Rehovot (IL)
  • LAZAROVITS, Janette
    Reut (IL)
  • GUY, Rachel
    Rehovot (IL)
  • LIPSCHITZ, Orly
    Rishon Lezion (IL)
  • SZANTON, Esther
    Rehovot (IL)
  • LEVANON, Avigdor
    Rehovot (IL)
  • PLAKSIN, Daniel
    Rehovot (IL)
  • PERETZ, Tuvia
    Hod Hasharon (IL)

(74) Representative: Mallalieu, Catherine Louise et al
D. Young & Co.,21 New Fetter Lane
London EC4A 1DA
London EC4A 1DA (GB)

   


(54) SPECIFIC HUMAN ANTIBODIES FOR SELECTIVE CANCER THERAPY